Navigation Links
Watson to Present at the 2010 Citi Investment Research Global Healthcare Conference

MORRISTOWN, N.J., May 14 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Fred Wilkinson, Watson's Executive Vice President, Global Brands, will provide an overview of the Company's business at the 2010 Citi Investment Research Global Healthcare Conference on Wednesday, May 26, 2010 at 4:30pm Eastern Daylight Time. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at  The webcast can also be accessed at the following URL:

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on urology and women's health. Watson has operations in many of the world's established and growing international markets.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at

(Logo: )

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Reaches Settlement with Teva Over Seasonale(R)
2. Watson Confirms EVISTA(R) Patent Challenge
3. Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 7th
4. Watson To Present at Bank Of America/Merrill Lynch 2010 Healthcare Conference
5. Watson Confirms Trilipix(R) Patent Challenge
6. Watson Confirms Rapamune(R) Patent Challenge
7. Watson Confirms Cenestin(R) Patent Challenge
8. Watson Says Appeals Court Affirms Concerta(R) Patent Invalid
9. Watson to Present at Barclays 2010 Global Healthcare Conference
10. Watson Receives FDA Approval for Generic Cardizem(R) LA
11. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... --> adds "Global Repaglinide ... "Investigation Report on China Repaglinide Market, ... forecasts data and information to its ... . --> ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
Breaking Medicine Technology:
(Date:11/28/2015)... PITTSBURGH, PA (PRWEB) , ... November 28, 2015 , ... ... to the creativity of two inventors, one from Lakewood, New Jersey and the other ... They developed the patent-pending PROTECTOR to save the expense of having to replace NuvaRings ...
(Date:11/28/2015)... ... ... at 6:00 a.m. EST until 11:59 p.m. EST, customers will be racing ... off orders $80 or more to free gifts with purchases, there will be a new ... e-commerce website for skin care and cosmetic needs, customers will save on already discounted prices. ...
(Date:11/27/2015)... Canada (PRWEB) , ... November 28, 2015 , ... There ... do we outperform our billings from last year? , This question has not been ... organizations are coming to the retirement age and the younger workforce don’t share the ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... and the University of British Columbia suggested that laws requiring bicyclists to wear helmets ... that part of the reason for the controversial conclusion is that, while helmets have ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the health care in America. As people age, more care is needed, especially ... are rising, and medical professionals are being overworked. The forgotten part of this ...
Breaking Medicine News(10 mins):